SPY334.33+2.22 0.67%
DIA273.90+1.90 0.70%
IXIC11,108.07+109.67 1.00%

Stifel Nicolaus Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $45

Stifel Nicolaus maintains Aerie Pharmaceuticals (NASDAQ:AERI) with a Buy and lowers the price target from $77 to $45.

Benzinga · -

Stifel Nicolaus maintains Aerie Pharmaceuticals (NASDAQ:AERI) with a Buy and lowers the price target from $77 to $45.